294 related articles for article (PubMed ID: 18632638)
1. Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer.
Aponte M; Jiang W; Lakkis M; Li MJ; Edwards D; Albitar L; Vitonis A; Mok SC; Cramer DW; Ye B
Cancer Res; 2008 Jul; 68(14):5839-48. PubMed ID: 18632638
[TBL] [Abstract][Full Text] [Related]
2. Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells.
Yu Y; Zhang M; Zhang X; Cai Q; Zhu Z; Jiang W; Xu C
J Exp Clin Cancer Res; 2014 Sep; 33(1):85. PubMed ID: 25261977
[TBL] [Abstract][Full Text] [Related]
3. Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epithelium.
Zhang L; Wang D; Jiang W; Edwards D; Qiu W; Barroilhet LM; Rho JH; Jin L; Seethappan V; Vitonis A; Wang J; Mok SC; Crum C; Cramer DW; Ye B
Reprod Biol Endocrinol; 2010 Jun; 8():74. PubMed ID: 20576130
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor induces platelet-activating factor production through receptors transactivation and cytosolic phospholipase A2 in ovarian cancer cells.
Yu Y; Zhang X; Hong S; Zhang M; Cai Q; Jiang W; Xu C
J Ovarian Res; 2014; 7():39. PubMed ID: 24721622
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of combined platelet-activating factor receptor and epidermal growth factor receptor targeting in ovarian cancer cells.
Yu Y; Zhang M; Zhang X; Cai Q; Hong S; Jiang W; Xu C
J Hematol Oncol; 2014 May; 7():39. PubMed ID: 24886678
[TBL] [Abstract][Full Text] [Related]
6. The Platelet-Activating Factor Receptor's Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine.
Deuster E; Hysenaj I; Kahaly M; Schmoeckel E; Mayr D; Beyer S; Kolben T; Hester A; Kraus F; Chelariu-Raicu A; Burges A; Mahner S; Jeschke U; Trillsch F; Czogalla B
Cells; 2021 Sep; 10(9):. PubMed ID: 34571986
[TBL] [Abstract][Full Text] [Related]
7. [Effects and mechanisms of platelet-activating factor on the invasiveness of ovarian cancer cells in vitro].
Jiang W; Wang YS; Cong Q; Li MJ; Ye B; Xu CJ
Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):931-5. PubMed ID: 22333285
[TBL] [Abstract][Full Text] [Related]
8. Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor.
Gao T; Yu Y; Cong Q; Wang Y; Sun M; Yao L; Xu C; Jiang W
BMC Cancer; 2018 Oct; 18(1):999. PubMed ID: 30340558
[TBL] [Abstract][Full Text] [Related]
9. Activation of platelet-activating factor receptor-coupled G alpha q leads to stimulation of Src and focal adhesion kinase via two separate pathways in human umbilical vein endothelial cells.
Deo DD; Bazan NG; Hunt JD
J Biol Chem; 2004 Jan; 279(5):3497-508. PubMed ID: 14617636
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by platelet-activating factor of Src- and hepatocyte growth factor-dependent invasiveness of intestinal and kidney epithelial cells. Phosphatidylinositol 3'-kinase is a critical mediator of tumor invasion.
Kotelevets L; Noë V; Bruyneel E; Myssiakine E; Chastre E; Mareel M; Gespach C
J Biol Chem; 1998 Jun; 273(23):14138-45. PubMed ID: 9603913
[TBL] [Abstract][Full Text] [Related]
11. Activation and regulation of platelet-activating factor receptor: role of G(i) and G(q) in receptor-mediated chemotactic, cytotoxic, and cross-regulatory signals.
Brown SL; Jala VR; Raghuwanshi SK; Nasser MW; Haribabu B; Richardson RM
J Immunol; 2006 Sep; 177(5):3242-9. PubMed ID: 16920964
[TBL] [Abstract][Full Text] [Related]
12. The expression of platelet-activating factor receptor modulates the cisplatin sensitivity of ovarian cancer cells: a novel target for combination therapy.
Yu Y; Zhang X; Hong S; Zhang M; Cai Q; Zhang M; Jiang W; Xu C
Br J Cancer; 2014 Jul; 111(3):515-24. PubMed ID: 24921917
[TBL] [Abstract][Full Text] [Related]
13. Paxillin-Y118 phosphorylation contributes to the control of Src-induced anchorage-independent growth by FAK and adhesion.
Sachdev S; Bu Y; Gelman IH
BMC Cancer; 2009 Jan; 9():12. PubMed ID: 19138410
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis.
Melnikova VO; Balasubramanian K; Villares GJ; Dobroff AS; Zigler M; Wang H; Petersson F; Price JE; Schroit A; Prieto VG; Hung MC; Bar-Eli M
J Biol Chem; 2009 Oct; 284(42):28845-55. PubMed ID: 19703903
[TBL] [Abstract][Full Text] [Related]
15. Platelet-Activating Factor-Receptor Signaling Mediates Targeted Therapies-Induced Microvesicle Particles Release in Lung Cancer Cells.
Chauhan SJ; Thyagarajan A; Chen Y; Travers JB; Sahu RP
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198218
[TBL] [Abstract][Full Text] [Related]
16. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
Johnson FM; Saigal B; Talpaz M; Donato NJ
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784
[TBL] [Abstract][Full Text] [Related]
17. G-protein-independent activation of Tyk2 by the platelet-activating factor receptor.
Lukashova V; Asselin C; Krolewski JJ; Rola-Pleszczynski M; Stanková J
J Biol Chem; 2001 Jun; 276(26):24113-21. PubMed ID: 11309383
[TBL] [Abstract][Full Text] [Related]
18. Intracellular Progesterone Receptor and cSrc Protein Working Together to Regulate the Activity of Proteins Involved in Migration and Invasion of Human Glioblastoma Cells.
Bello-Alvarez C; Moral-Morales AD; González-Arenas A; Camacho-Arroyo I
Front Endocrinol (Lausanne); 2021; 12():640298. PubMed ID: 33841333
[TBL] [Abstract][Full Text] [Related]
19. Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma.
Madan R; Smolkin MB; Cocker R; Fayyad R; Oktay MH
Hum Pathol; 2006 Jan; 37(1):9-15. PubMed ID: 16360410
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
